Delivery Order SPE2DB22D1106-SPE2DB25FEYT2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,416.10 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,163.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, to support military treatment programs and facilities. The delivery order has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,351.14 on July 21, 2025, for the supply of Proctofoam 10GM by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. This firm fixed-price, competitively awarded delivery order is scheduled for completion by July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract, valued at $1,735.56, is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp has also been awarded an indefinite delivery contract (IDC) by DLA with a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,807.64 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of July 12, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,156.42 to Amerisourcebergen Drug Corp's Corporate Office division for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract, valued at $1,276.50, is a delivery order for PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies to the U.S. Defense Logistics Agency (DLA). The $1,132.55 firm-fixed-price delivery order was awarded on June 30, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has a completion date of July 1, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,603.16 on July 30, 2025, for the supply of Proctofoam 10GM. This firm fixed price, non-competitive delivery order is set to be completed by July 31, 2025, and falls under a child contract associated with the Defense Logistics Agency's Medical Supply Chain. The place of performance is located in Conshohocken, Pennsylvania, reflecting...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,983.12 to AmerisourceBergen Drug Corp on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contractor,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYT2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cortifoam 10% Aerosol 15GM pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $6,638.37 under a firm fixed price contract structure, with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA contract portfolio demonstrates extensive capability in delivering a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, from brand-name and generic medications to vaccines and specialized medical devices. The SPE2DX prime contract vehicle enables AmerisourceBergen to supply pharmaceutical commodities to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/18/25 |